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Abstract
Background: Relationships between socioeconomic status (SES) and the risk factors, applied 
treatment and outcomes of patients with coronary artery disease (CAD) have been demonstrated in 
Western European countries, however analogous evidence is missing from Eastern and Central Euro­
pean countries. The aim of the study was to investigate SES gradients regarding the risk factors, 
symptoms and management of patients with stable CAD in Poland, separately in men and women.
Methods: We analyzed the data of 2,593 participants of the RECENT study. SES was assessed 
based on the level of education attainment: university, secondary school or primary school.
Results: Socioeconomic differences in risk profile were most markedly seen in women: lower the 
education, higher body mass index (p < 0.01), systolic and diastolic blood pressure (p < 0.05),  
resting heart rate (p < 0.01), and greater prevalence of heart failure (p < 0.05) and dyslipidemia  
(p < 0.05). Importantly, smoking habit was the most frequent in women who graduated from univer­
sity (p < 0.01). In men, socioeconomic gradients were only seen within resting heart rate (p < 0.01),  
LDL cholesterol level (p < 0.05) and smoking habit (p < 0.05). In both genders, better education was 
associated with less severe symptoms of angina and more frequent use of statins (p < 0.05).
Conclusions: SES stratified based on education level differentiates patients with stable CAD 
in Poland regarding their risk profile, symptom control and the use of statins. Sexual dimor­
phism is found mainly within SES gradients regarding the prevalence of risk factors. (Cardiol J  
2015; 22, 5: 487–494)
Key words: socioeconomic status, stable coronary artery disease, risk factors,  
sexual differences, treatment, symptom control
Editorial p. 477
487www.cardiologyjournal.org
ORIGINAL ARTICLE
Cardiology Journal 
2015, Vol. 22, No. 5, 487–494
DOI: 10.5603/CJ.a2015.0016
Copyright © 2015 Via Medica
ISSN 1897–5593
Introduction
Coronary artery disease (CAD) is described 
as one of the major causes of death worldwide 
[1, 2]. In the Polish population, CAD is estimated to 
affect over 1 million of individuals, and in 2012 led 
to 45,850 deceases [3]. The population of patients 
with CAD is heterogeneous in many aspects, in-
cluding the socioeconomic status (SES) [4]. SES 
has been found to be associated with the risk of 
CAD, its prevalence and treatment, as well as late 
outcomes in patients after myocardial infarction 
(MI) in the Unites States and Western European 
countries [5–11]. However, there is no analogous 
evidence for Poland. It is not obvious if such as-
sociations are present in Eastern European coun-
tries due to economic, education and healthcare 
differences. Although several cardiovascular risk 
factors, such as hypertension, abdominal obesity, 
hyperglycemia were found to be more prevalent in 
low educated Polish women [12, 13] and higher car-
diovascular mortality was shown in low educated 
citizens of Warsaw and Tarnobrzeg [14]. Never-
theless, the aforementioned studies were limited 
to the analysis of few factors in the selected local 
communities, so it is not possible to assign these 
results to the whole Polish population.
Gender is a risk factor of CAD itself. Fur-
ther, there is a clear sexual dimorphism seen in 
European population regarding epidemiology, 
symptomatology, treatment and outcomes of CAD 
[15–17]. There are also well known gender differ-
ences in SES gradients regarding the prevalence 
of hypertension and metabolic syndrome in Poland 
[12, 13], hence it is justified to analyze men and 
women separately.
SES is conditioned by a broad range of factors, 
among which the most significant are: education, 
occupation and income. Education level, due to its 
high correlation with the two others, constitutes 
the most commonly used SES measure in epidemi-
ological studies [18], also in those regarding CAD 
[9, 18, 19]. Moreover, education among other SES 
measurements was found to be the strongest and 
most consistent determinant of CAD risk factors 
prevalence in Poland [20] as well as MI occurrence 
in another Eastern European country — Czech 
Republic [21], and was also applied in our analysis.
In the present study, we investigated, consid-
ering gender stratification, the association between 
SES and cardiovascular risk factors, symptoms and 
applied treatment in the large representative popu-
lation of Polish stable CAD patients, participating 
in the RECENT study [4].
Methods
Study design
The selection of the participating physicians, 
the enrolment of patients and the data collection 
protocol of the RECENT study were described 
accurately elsewhere [4]. 
Study group
The representative group of 2,593 patients 
(1,466 men and 1,127 women) was enrolled by 
the previously chosen ambulatory care physicians 
(general practitioners and specialists) in Poland. 
All healthcare professionals were obliged to en-
rol, within 14 days of recruitment period, up to 
10 consecutive patients with confirmed CAD that 
had been treated for at least 12 months. Out of this 
group, 22 subjects were excluded from the analysis 
due to the lack of the data regarding educational 
status which was crucial for the study. Detailed 
recruitment scheme and criteria were described 
elsewhere [4].
Questionnaire
Forms were filled in anonymously by physi-
cians on each participant of the study. Detailed 
information about the questionnaire content was 
presented elsewhere [4, 22].
Ethics
The Ethics Committee approved the study 
protocol. All subjects gave written informed con-
sent before the study entry.
Data management
The data on SES, physical examination and 
medical history were obtained from the study 
questionnaire. Regarding the reported level of 
educational attainment, patients were divided into 
three groups:
 — primary education group (PEG) containing 
subjects, who completed primary school or 
never attended to school;
 — secondary education group (SEG) with sub-
jects who completed technical or secondary 
school;
 — highly educated group (HEG) consisted of 
participants who graduated from university 
(or equivalent).
We analyzed the following variables catego-
rized into four groups:
 — 1 — cardiovascular risk factors: age, body 
mass index (BMI), current office systolic and 
diastolic blood pressure (SBP and DBP), office 
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heart rate, low density lipoprotein cholesterol 
(LDL-C) level, smoking status, hypertension 
in medical history, dyslipidemia in medical 
history, diabetes;
 — 2 — cardiovascular disorders: past MI, stroke 
and/or transient ischemic attack (TIA) in medical 
history, peripheral artery disease or heart failure;
 — 3 — symptom control: Canadian Cardiac So-
ciety (CCS) class, all participants were also 
asked about: the number of chest pain episodes 
over the week preceding the study, the number 
of used nitroglycerin doses over the week 
preceding the study and about chest pain oc-
currence over 3 months preceding the study;
 — 4 — applied treatment:
• invasive treatment: percutaneous coro-
nary intervention (PCI) and/or coronary 
artery bypass grafting (CABG) in medical 
history;
• use of: antiplatelets (aspirin and/or clopi-
dogrel), statins, beta-blockers, angio-
tensin-converting-enzyme inhibitors or 
angiotensin II receptor blockers (ACEI or 
ARB), calcium-channel blockers (CCB), 
long-acting nitrates, trimetazidine;
• use of combination of life-saving drugs 
(ACEI/ARB, statin and antiplatelet);
• use of any of symptomatic drugs (beta-
-blocker and/or CCB and/or trimetazidine 
and/or long-acting nitrate).
Statistical analysis
The data were analyzed using Statistica 10 
(StatSoft Inc., Tulsa, USA). The subgroups char-
acteristics, comorbidities, applied treatment and 
symptom control factors were presented by means 
of descriptive statistics. Variables were expressed 
as mean with standard deviation. The differences 
between the examined subgroups were checked us-
ing c2 test with appropriate weights for qualitative 
variables and 1-factor ANOVA test with appropriate 
weights for quantitative variables. P-value < 0.05 
was considered statistically significant.
Results
Sample structure
Among 1,428 men included in the analysis, 
834 (57%) reported primary education, 430 (29%) 
reported secondary education and 188 (13%) 
graduated from university. Analogously, among 
1,113 women 689 (62%) were assigned to PEG, 
336 (30%) to SEG and 81 (7%) to HEG.
Cardiovascular risk profile
Generally, SES gradients regarding the preva-
lence of cardiovascular risk factors were markedly 
seen in women. Women with primary education 
were older than in SEG and HEG. Almost all 
measured quantitative risk factors, such as BMI, 
SBP, DBP were the higher the lower the level of 
education was. A trend in greater prevalence of 
hypertension in PEG, than in SEG and HEG was 
also found, however, the difference did not reach 
the level of statistical significance (p = 0.05). In 
contrast to the aforementioned risk factors, dys-
lipidemia was diagnosed the more frequent, the 
higher the SES (Table 1).
In males, higher level of educational attain-
ment was associated with lower LDL-C levels 
(Table 1). This was not observed in women.
SES gradient within heart rate were same in 
both genders — heart rate was the lowest in HEG 
in men and women. SES gradients within smoking 
habits were also observed in both genders, how-
ever, differences were inverse comparing men and 
women. In men, smoking was the most prevalent 
in PEG, on the contrary, in women it was related 
to high education (Table 1).
There were no SES differences in the preva-
lence of diabetes in both sexes (Table 1).
Cardiovascular disorders
SES gradient was seen only in the prevalence 
of heart failure and only in women. There were no 
SES differences in an incidence of peripheral artery 
disease, stroke/TIA or MI (Table 1).
Symptom control
There were SES gradients regarding the 
angina symptom control in both genders when as-
sessed using CCS class (Fig. 1) and the number of 
used nitroglycerin doses over the week preceding 
the study (Fig. 2B). Both measures showed that the 
lower the level of education, the more exaggerated 
the symptoms.
Analogous pattern was shown for chest pain 
occurrence over 3 months preceding the study. 
An episode of the typical pain over previous 
3 months was reported by men in 62% vs. 53% vs. 
49%; p < 0.01 and by women in 66% vs. 57% vs. 
54%; p < 0.01, for PEG vs. SEG vs. HEG, respec-
tively.
The number of chest pain episodes over the 
week preceding the study was significantly higher 
in PEG in comparison to SEG and HEG in both 
genders (Fig. 2A).
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Applied treatment
There were no statistically significant SES dif-
ferences within PCI and CABG appliance, however 
the trend toward more frequent CABG in HEG was 
observed in men (p = 0.05) (Table 2).
Regarding pharmacotherapy, SES gradients in 
both men and women were found only in the use of 
statins, whose frequency of prescription depended 
on the quality of SES.
Figure 2. Numbers of chest pain episodes over the week preceding the study (A) and numbers of applied nitroglycerin 
doses over the week preceding the study (B) according to socioeconomic status (SES) in Polish men and women 
with stable coronary artery disease; PEG — primary education; SEG — secondary education; HEG — high education.
Figure 1. Canadian Cardiac Society (CCS) class structure according to socioeconomic status in Polish men and women 
with stable coronary artery disease; PEG — primary education; SEG — secondary education; HEG — high education.
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The usage of long-acting nitrates (LANs) and 
anti-platelets was different among SES groups only 
in females. LANs were less frequently used when 
the education was higher. As for anti-platelets, 
these drugs were less frequently applied in SEG 
than in PEG and HEG (Table 2).
No other SES gradients were found among the 
analyzed medications (Table 2).
Discussion
Our analysis of the stable CAD population of 
the RECENT study revealed that: (1) SES gradi-
ents within the cardiovascular risk factors are seen 
mainly in women, (2) the higher the level of SES, 
the better the symptom control in both genders, 
and (3) despite the differences in the symptom 
control, there are only few SES gradients within 
applied treatment of CAD, regarding statin use in 
both genders, as well as antiplatelet and LAN use 
in women.
The results of our analysis are quite concord-
ant with the results of Mayer’s et al. [9] study of the 
European, multi-country, CAD population, where 
inverse relationships between SES, and the CAD 
risk factors, and applied pharmacological treatment 
were found. However, some SES gradients differ 
in Poland, which may be the result of trends seen 
in the general Polish population.
To begin with, in our analysis, SES gradients 
regarding the prevalence of CAD risk factors are 
much more frequent in women than in men. Thus, 
on the contrary to the European population [9], 
in Poland, SES gradients in mean DBP and SBP 
are found in women instead of men. This finding 
is in accordance with trends seen in the general 
Polish population, where low level of education 
was reported to be associated with higher risk 
of hypertension in women but not in men [12]. 
Furthermore, the relationship between low edu-
cation level and BMI, in our analysis, is present 
only in women, when EUROASPIRE II sub-study 
showed such a regularity for both sexes. Tobacco 
consumption is reported to be inversely related to 
the level of education in European CAD popula-
tions [9, 11]. In contrast to these data, we found 
a straight relationship between SES and smoking 
in women — smoking rate is the highest in HEG 
group. This difference may be a result of changes 
seen in Eastern European societies since early 
1990s, where apart from transient increase in 
premature mortality of working-age men (mainly 
due to CAD) and changes in drinking habits, the 
increase in tobacco consumption in women was 
observed [23, 24].
To the best of our knowledge, our study pro-
vides for the first time the association between 
angina control and SES. Apart from CCS class we 
Table 2. Socioeconomic gradients in the treatment of coronary artery disease in Polish man and women 
with stable angina.
Men Women
Education level c² (p) c² (p) Education level
PEG SEG HEG PEG SEG HEG
PCI [%] 26 30 31 3.57 (0.17) 0.74 (0.69) 13 14 16
CABG [%] 16 20 22 5.95 (0.05) 4.65 (0.1) 9 12 15
Antiplatelets (%) 83 82 83 0.08 (0.96) 7.62 (0.02) 81 74 82
Statin [%] 74 78 83 8.95 (0.01) 7.6 (0.02) 65 71 78
Beta-blocker [%] 80 83 83 1.48 (0.48) 1.33 (0.51) 80 80 85
ACEI or ARB [%] 81 83 83 1.22 (0.54) 3.33 (0.19) 80 76 74
Calcium-channel blocker [%] 21 23 23 0.67 (0.7) 4.71 (0.1) 26 32 27
Long-acting nitrate [%] 52 51 45 2.59 (0.27) 14.5 (< 0.01) 60 49 44
trimetazidine [%] 12 11 16 3.17 (0.2) 1.0 (0.6) 15 15 11
Life-saving drugs* [%] 54 58 57 1.67 (0.43) 0.61 (0.61) 48 47 52
Any of symptomatic drugs** [%] 95 95 95 0.07 (0.96) 0.97 (0.61) 97 98 96
*ACEI/ARB, statin, antiplatelet; **Beta-blocker and/or calcium-channel blocker and/or trimetazidine and/or long-acting nitrate; PEG — primary 
education; SEG — secondary education; HEG — high education; PCI — percutaneous coronary intervention; CABG — coronary artery bypass 
grafting; ACEI — angiotensin-converting-enzyme inhibitor; ARB — angiotensin II receptor blocker
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used the number of used nitroglycerin doses and 
the number of chest pain episodes experienced in 
the week preceding the study as well as the oc-
currence of the typical chest pain over 3 months 
preceding the study to determine the severity of 
symptoms. According to the results of our analy-
sis, clear SES gradients in the occurrence of CAD 
symptoms are seen in all used measurements, in 
both genders. This finding is difficult to explain 
simply with the differences in applied treatment. 
No SES gradient within invasive treatment reaches 
the level of statistical significance, use of LAN is 
also the lowest in HEG. Nevertheless, our results 
may help understand the data presented by Cohen 
et al. [25], who revealed, using treadmill exercise 
test, lower functional capacity in low educated 
CAD population.
The adherence to CAD life-saving medications 
in Poland is independent of the level of education 
with two exceptions. Statins, same as it was found 
by Mayer et al. [9] in the population of 15 European 
countries, are more frequently administered in 
HEG individuals of both genders, which reflects 
in lower LDL-C levels in that group (difference 
significant only in men). Antiplatelets are less 
frequently used by women in SEG. This finding 
cannot be explained by lower appliance of PCI in 
that group or higher rates of atrial fibrillation (data 
not presented) whose treatment may influence 
antiplatelet therapy, and needs to be explained in 
future studies. Among symptomatic drugs, prob-
ably as a result of more exaggerated symptoms, 
the usage of long-lasting nitrates is the higher the 
lower SES is, however this gradient is statistically 
significant only in women.
The strongest side of our analysis is the unique 
sample drawing scheme, which allowed us to ana-
lyze a representative group of stable CAD patients, 
treated in primary care settings and outpatients 
clinics across Poland. Hence, the results of the 
analysis describe everyday real-live patients. Ma-
jority of studies concerning CAD population cited 
here were recruiting patients after hospitalization 
due to acute coronary syndrome or after invasive 
coronary revascularization [9, 11]. Hospital stay 
due to acute coronary syndrome improves further 
drug prescriptions, compliance and adherence itself 
[26–28], same invasive treatment increases use of 
antiplatelets and reduces symptomatic drugs use 
due to the procedure itself.
Limitations of the study
There are also several limitations to the study. 
First of all, it was a questionnaire based study, so 
the questionnaire bias cannot be excluded. How-
ever, the questionnaires were filled by physicians 
based on patients’ medical history, which reduced 
potential misunderstanding of questions and pro-
vided an opportunity to ask participants additional 
questions if the response was inaccurate. Secondly, 
the level of education was the only factor used to 
determine SES. Nevertheless, the factor is the 
most consistent and the strongest determinant of 
health, and is most commonly used in epidemio-
logical studies [18].
Conclusions
Our analysis revealed that SES differentiates 
Polish population of patients with stable CAD. High 
education, independently of gender, is associated 
with better symptom control and higher appliance 
of statins. Sexual dimorphism is particularly well 
seen in SES gradients regarding the CAD risk fac-
tors — risk profile of low educated women is worse 
than of low educated men. Sexual differences are 
also present in the use of LAN.
The results of our study would be important 
and help understand the effect of SES on health of 
our patients and  identify groups (e.g. low educated 
women) which need intensified medical attention in 
terms of preventive lifestyle changes and compli-
ance with evidence-based pharmacotherapy.
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